Coherus Oncology CHRS
NASDAQ CHRS
$0.75 +0.00 (+0.36%)
As of: Nov 6, 2026 · 10:06 AM EST

Coherus Oncology (CHRS) EV to FCF (2019 - 2026)

Updated

Coherus Oncology's EV to FCF was 0.31 in Q1 2026, down 4.1% from 0.32 a year earlier.

Analysis

Coherus Oncology (CHRS) EV to FCF (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Coherus Oncology's EV to FCF was -1.67 through Mar 31, 2026; for FY2025, it came in at 0.00.

  • In earlier years, EV to FCF was 0.16 in FY2024.
  • Quarterly EV to FCF has moved between -0.41 (Q2 2025) and 16.48 (Q3 2021) over five years.
  • Per Business Quant data, CHRS's EV to FCF in the three quarters before Q1 2026 was 0.00 (Q4 2025), 0.00 (Q3 2025) and -0.41 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,221.28 Bn 1,194.89 Bn 20.46 Bn
2 Johnson & Johnson 653.62 Bn 573.48 Bn 17.30 Bn
3 AbbVie 509.01 Bn 477.02 Bn 13.12 Bn
4 Merck 362.31 Bn 325.26 Bn 13.19 Bn
5 Novartis Ag 312.49 Bn 285.73 Bn -
6 Astrazeneca 285.84 Bn 259.73 Bn 13.26 Bn
7 Amgen 248.19 Bn 199.85 Bn 7.58 Bn
8 Gilead Sciences 208.17 Bn 183.27 Bn 6.73 Bn
9 Pfizer 166.64 Bn 114.00 Bn 12.56 Bn
10 Coherus Oncology 116.82 Mn -519.32 Mn 10.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 0.31
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 -0.41
Mar 31, 2025 0.32
Dec 31, 2024 0.16
Sep 30, 2024 0.13
Jun 30, 2024 0.23
Mar 31, 2024 0.33
Sep 30, 2021 16.48
Jun 30, 2021 7.73
Mar 31, 2021 4.90
Dec 31, 2020 4.89
Sep 30, 2020 6.19
Jun 30, 2020 5.82
Mar 31, 2020 10.02
Dec 31, 2019 41.04
API Access

Coherus Oncology EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=CHRS&period=max&api_key=YOUR_API_KEY